“…Additional metrics, especially epithelial thickness mapping with very high frequency ultrasound 25,26 or high-resolution optical coherence tomography, 27,28 can differentiate keratoconic and normal eyes and seem promising for detecting early corneal ectatic processes. Other hopeful but as yet unvalidated techniques include biomechanical characterization using the Ocular Response Analyzer (Reichert, Buffalo, NY), which, although theoretically promising, 10 has demonstrated limited ability in screening for ectatic diseases, 29,30 and the recently FDA-approved Oculus Corvis ST. 31 Ambrósio & Randleman/Editorial SUMMARY: SCREENING TODAY So, what should we be using to screen our patients in 2013?…”